TrialDiabetes, obesity & metabolism2021

Results from the Effects of MEtformin on cardiovasculaR function in AdoLescents with type 1 Diabetes (EMERALD) study: A brief report of kidney and inflammatory outcomes.

Kalie L Tommerdahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.